Lower Drug Costs: Expanded Price Negotiation and Rebates for Americans
This bill aims to reduce drug costs for more Americans by expanding the drug price negotiation program. This means the government can negotiate prices for more drugs and for a wider range of individuals, including those with private insurance plans. Additionally, it introduces mechanisms to ensure that rebates for drugs whose prices rise faster than inflation are also applied in the commercial market, potentially leading to lower prices for patients.
Key points
The government will be able to negotiate prices for 50 drugs annually, up from 20, increasing the number of drugs with potentially lower costs.
The drug price negotiation program will extend to individuals with private health insurance, potentially reducing their out-of-pocket drug expenses.
Health insurers and plans will be required to apply negotiated lower drug prices, and their participation in the program will be automatic unless they explicitly opt out.
Mechanisms are introduced to ensure that rebates for drugs with prices rising faster than inflation are also applied in the commercial market, potentially lowering costs for all patients.
Expired
Citizen Poll